State Street’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.8M | Sell |
2,532,154
-329,066
| -12% | -$3.75M | ﹤0.01% | 1982 |
|
|
2025
Q1 | $34M | Buy |
2,861,220
+57,960
| +2% | +$689K | ﹤0.01% | 1834 |
|
|
2024
Q4 | $52.8M | Buy |
2,803,260
+431,989
| +18% | +$8.14M | ﹤0.01% | 1690 |
|
|
2024
Q3 | $53.3M | Sell |
2,371,271
-337,262
| -12% | -$7.58M | ﹤0.01% | 1675 |
|
|
2024
Q2 | $56.5M | Sell |
2,708,533
-20,803
| -0.8% | -$434K | ﹤0.01% | 1612 |
|
|
2024
Q1 | $40.1M | Buy |
2,729,336
+1,808,014
| +196% | +$26.6M | ﹤0.01% | 1836 |
|
|
2023
Q4 | $9.51M | Sell |
921,322
-852,746
| -48% | -$8.8M | ﹤0.01% | 2620 |
|
|
2023
Q3 | $13.9M | Sell |
1,774,068
-151,658
| -8% | -$1.19M | ﹤0.01% | 2400 |
|
|
2023
Q2 | $19.2M | Sell |
1,925,726
-309,552
| -14% | -$3.09M | ﹤0.01% | 2263 |
|
|
2023
Q1 | $19.8M | Sell |
2,235,278
-272,709
| -11% | -$2.42M | ﹤0.01% | 2237 |
|
|
2022
Q4 | $27.5M | Buy |
2,507,987
+195,763
| +8% | +$2.15M | ﹤0.01% | 2017 |
|
|
2022
Q3 | $30.1M | Buy |
2,312,224
+195,453
| +9% | +$2.55M | ﹤0.01% | 1941 |
|
|
2022
Q2 | $26.8M | Sell |
2,116,771
-185,773
| -8% | -$2.35M | ﹤0.01% | 2040 |
|
|
2022
Q1 | $32.3M | Buy |
2,302,544
+744,832
| +48% | +$10.4M | ﹤0.01% | 2054 |
|
|
2021
Q4 | $45.1M | Sell |
1,557,712
-75,419
| -5% | -$2.18M | ﹤0.01% | 1878 |
|
|
2021
Q3 | $48.9M | Sell |
1,633,131
-226,337
| -12% | -$6.78M | ﹤0.01% | 1823 |
|
|
2021
Q2 | $49.3M | Buy |
1,859,468
+481,606
| +35% | +$12.8M | ﹤0.01% | 1860 |
|
|
2021
Q1 | $42.8M | Buy |
1,377,862
+926,630
| +205% | +$28.8M | ﹤0.01% | 1859 |
|
|
2020
Q4 | $14.8M | Buy |
451,232
+319,559
| +243% | +$10.5M | ﹤0.01% | 2412 |
|
|
2020
Q3 | $4.6M | Buy |
+131,673
| New | +$4.6M | ﹤0.01% | 2825 |
|